The financials
AstraZeneca PLC by the numbers
AstraZeneca PLC (AZN) reported revenue of $30.7B in H2 2025 (quarter ended December 31, 2025), up 137% from the same quarter a year earlier. That came with a gross margin of 81% and net income of $4.86B (16% of revenue). For the full year FY2025, revenue was $58.7B (+8.6% year on year) and net income $10.2B.
| Income statement | H2 2025 | Q2 2024 | Change |
|---|---|---|---|
| Revenue | $30.7B | $12.9B | +137% |
| Gross profit | $24.8B | $10.8B | +130% |
| Operating income | $6.56B | $2.75B | +139% |
| Net income | $4.86B | $1.93B | +152% |
| Diluted EPS | $3.10 | $1.24 | +150% |
Drug Manufacturers - General
Ranks #3 of 16 by Smart Score